Hinge Health, Inc.

Listed Company

HNGECIK 0001673743NYSEEmerging GrowthServices-Computer Processing & Data PreparationDelawareFY ends Dec 31

Period

FY 2025

Revenue

$587.86M

Net Income

$-528.26M

Total Assets

$744.76M

Equity

$178.66M

Shares Out

Op. Cash Flow

$171.44M

HNGE$87.09+86.99% · past yearDBEQ Basic

Daily closing prices

Business

Hinge Health is a digital musculoskeletal care platform that uses AI-powered motion tracking, wearable electrical nerve stimulation devices, and a multidisciplinary care team to deliver remote physical therapy and pain management. The platform addresses joint and muscle health across 16 affected body areas through chronic, acute, post-surgical, preventive, and specialized programs including women's pelvic health and fall prevention. Hinge Health serves self-insured employers, health plans, Medicare Advantage populations, and government entities directly and through partnerships with major health plans, PBMs, and TPAs, with contracts typically spanning three years.

Summary from 10-K filed 2026-07-01

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Revenue	588	390	293
Cost of revenue	120	91	99
Gross profit	468	300	194
Research and development	368	101	110
Sales and marketing	317	167	148
General and administrative	330	64	67
Total operating expenses	1,015	332	325
Loss from operations	−546	−32	−131
Other income, net	19	21	22
Net loss before income taxes	−527	−11	−109
Provision for (benefit from) income taxes	998,000	677,000	−405,000
Net loss	−528	−12	−108
Adjustment to reflect deemed contribution from Series D and Series E redeemable convertible preferred stock extinguishment	104	0	0
Net loss attributable to common stockholders	−424	−12	−108
Net income (loss) per share attributable to common stockholders, basic (in usd per share)	−7.77	−0.88	−8.31
Net income (loss) per share attributable to common stockholders, diluted (in usd per share)	−7.77	−0.88	−8.31
Weighted average shares attributable to common stockholders, basic (in shares)	55	14	13
Weighted average shares attributable to common stockholders, diluted (in shares)	55	14	13
Unrealized gain (loss) on marketable securities, net of taxes	−88,000	8,000	135,000
Comprehensive loss	−528	−12	−108

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Cash and cash equivalents	208	301	235	—
Short-term marketable securities	156	166	—	—
Accounts receivable, net of allowance for credit losses of $6,092 and $6,470 as of December 31, 2025 and 2024, respectively	66	42	—	—
Deferred commissions	31	19	—	—
Inventory	16	11	—	—
Prepaid expenses and other current assets	57	45	—	—
Total current assets	534	583	—	—
Long-term marketable securities	113	0	—	—
Goodwill	64	62	—	—
Intangible assets, net	3	2	—	—
Property, equipment and software, net	10	7	—	—
Operating lease right-of-use assets	7	10	—	—
Other assets	14	9	—	—
Total assets	745	673	—	—
Accounts payable and accrued liabilities	57	28	—	—
Operating lease liabilities	4	4	—	—
Deferred revenue	301	218	—	—
Total current liabilities	362	249	—	—
Operating lease liabilities, noncurrent	4	7	—	—
Total liabilities	366	257	—	—
Commitments and contingencies (Note 6)	—	—	—	—
Redeemable convertible preferred stock, $0.00001 par value; 4,330,341 shares of Series E authorized, 2,581,837 shares of Series E preferred stock issued and outstanding as of December 31, 2025, 48,190,771 shares authorized and 48,150,146 shares issued and outstanding as of December 31, 2024; aggregate liquidation preference of $200,000 and $845,478 as of December 31, 2025 and 2024, respectively	200	851	851	851
Common stock, value	—	0	—	—
Additional paid-in capital	1,230	88	—	—
Accumulated other comprehensive gain (loss)	−20,000	68,000	—	—
Accumulated deficit	−1,051	−523	—	—
Total stockholders equity (deficit)	179	−435	−424	−318
Total liabilities, redeemable convertible preferred stock and stockholders equity (deficit)	745	673	—	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Depreciation and amortization	5	6	6
Stock-based compensation	643	739,000	2
Amortization of deferred commissions	47	30	20
Accretion of discounts and amortization of premiums on marketable securities, net	361,000	537,000	−11
Excess and obsolete inventory charge	0	2	10
Non-cash operating lease expense	3	4	3
Provision for credit losses	3	5	5
Deferred income taxes	53,000	−585,000	−473,000
Other	1,000	7,000	65,000
Accounts receivable	−27	−1	−23
Deferred commissions	−64	−39	−28
Inventory	−5	608,000	11
Prepaid expenses and other current assets	−16	−9	6
Other assets	−181,000	377,000	677,000
Accounts payable and accrued liabilities	29	−11	12
Operating lease liabilities	−4	−5	−4
Deferred revenue	83	77	36
Net cash provided by (used in) operating activities	171	49	−64
Purchase of property and equipment	−708,000	−1	−2
Capitalized internal use software	−5	−3	−3
Purchases of marketable securities	−472	−325	−453
Maturities of marketable securities	369	347	459
Acquisition of a business	−4	0	0
Net cash (used in) provided by investing activities	−114	18	2
Proceeds from exercise of common stock options	1	610,000	492,000
Issuance of common stock in connection with the employee stock purchase plan	8	0	0
Proceeds from issuance of common stock in initial public offering, net of issuance costs	256	0	0
Tax withholdings on settlement of restricted stock units and performance-based restricted stock units	−295	0	0
Payment on Repurchase Agreement with Coatue	−50	0	0
Proceeds from repayment of non-recourse loans to employees	5	0	0
Repurchase and retirement of common stock	−65	0	0
Cash paid on settlement of acquisition related holdback	0	0	−3
Payments for deferred offering costs	−10	−3	−645,000
Net cash used in financing activities	−150	−2	−3
Net increase (decrease) in cash	−93	65	−65
Cash paid for income taxes	2	0	0
Property and equipment purchased and unpaid at end of year	0	0	36,000
Stock-based compensation capitalized in internal-use software	1	0	0
Unpaid deferred offering costs at year end	20,000	210,000	389,000
Right-of-use assets obtained in exchange for lease obligations	686,000	0	1
Conversion of redeemable convertible preferred stock for Coatue in connection with initial public offering	151	0	0
Conversion of redeemable convertible preferred stock for all other in connection with initial public offering	347	0	0

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Hinge Health, Inc.'s CIK number?

Hinge Health, Inc.'s SEC CIK number is 0001673743 (1673743). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Hinge Health, Inc.'s SEC filings?

All of Hinge Health, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Hinge Health, Inc. last report earnings?

Hinge Health, Inc. (HNGE) most recently filed an earnings 8-K with the SEC on May 5, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001628280-26-030499). This is Hinge Health, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is Hinge Health, Inc.'s most recent earnings 8-K?

Hinge Health, Inc.'s latest earnings 8-K (Item 2.02) was filed May 5, 2026 under accession 0001628280-26-030499. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Hinge Health, Inc.'s latest earnings 8-K →
Look up any company's CIK number →